Alexandre Wicky

811 total citations
16 papers, 164 citations indexed

About

Alexandre Wicky is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexandre Wicky has authored 16 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexandre Wicky's work include Cancer Immunotherapy and Biomarkers (8 papers), Melanoma and MAPK Pathways (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Alexandre Wicky is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Melanoma and MAPK Pathways (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Alexandre Wicky collaborates with scholars based in Switzerland, United States and Italy. Alexandre Wicky's co-authors include Olivier Michielin, Michel A. Cuendet, Camille L. Gérard, Krisztián Homicskó, Julie Delyon, Aristomenis K. Exadaktylos, Pierre‐Nicolas Carron, Montserrat Fraga, Darius Moradpour and Haïthem Chtioui and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Alexandre Wicky

16 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Wicky Switzerland 6 94 43 42 37 18 16 164
Diego Enrico Argentina 8 136 1.4× 64 1.5× 45 1.1× 42 1.1× 10 0.6× 29 215
Aleigha Lawless United States 4 179 1.9× 54 1.3× 43 1.0× 48 1.3× 7 0.4× 21 218
Yu Yu China 5 139 1.5× 60 1.4× 53 1.3× 32 0.9× 11 0.6× 6 197
Laurien J. Zeverijn Netherlands 7 95 1.0× 47 1.1× 17 0.4× 81 2.2× 15 0.8× 24 205
David García-Illescas Spain 6 71 0.8× 53 1.2× 27 0.6× 35 0.9× 7 0.4× 15 156
Ryan Massa United States 6 176 1.9× 35 0.8× 72 1.7× 66 1.8× 11 0.6× 16 245
Meera Patel United States 6 81 0.9× 56 1.3× 20 0.5× 15 0.4× 8 0.4× 15 127
Kimberly Tang United States 5 133 1.4× 62 1.4× 33 0.8× 25 0.7× 7 0.4× 10 197
Yuequan Shi China 10 170 1.8× 89 2.1× 60 1.4× 43 1.2× 6 0.3× 27 265
Ramdane Belhocine France 9 67 0.7× 17 0.4× 42 1.0× 21 0.6× 7 0.4× 18 223

Countries citing papers authored by Alexandre Wicky

Since Specialization
Citations

This map shows the geographic impact of Alexandre Wicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Wicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Wicky more than expected).

Fields of papers citing papers by Alexandre Wicky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Wicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Wicky. The network helps show where Alexandre Wicky may publish in the future.

Co-authorship network of co-authors of Alexandre Wicky

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Wicky. A scholar is included among the top collaborators of Alexandre Wicky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Wicky. Alexandre Wicky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Courlet, Perrine, Daniel Abler, Monia Guidi, et al.. (2023). Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy. CPT Pharmacometrics & Systems Pharmacology. 12(8). 1170–1181. 7 indexed citations
2.
Wicky, Alexandre, Roberto Gatta, Sofiya Latifyan, et al.. (2023). Interactive process mining of cancer treatment sequences with melanoma real-world data. Frontiers in Oncology. 13. 1043683–1043683. 1 indexed citations
3.
Abler, Daniel, Perrine Courlet, Roberto Gatta, et al.. (2023). Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging. JCO Clinical Cancer Informatics. 7(7). e2200126–e2200126. 2 indexed citations
4.
Goldman, Jean-Philippe, Rita Achermann, Julien Gobeill, et al.. (2023). Multilingual RECIST classification of radiology reports using supervised learning. Frontiers in Digital Health. 5. 1195017–1195017. 2 indexed citations
5.
Cuendet, Michel A., Roberto Gatta, Alexandre Wicky, et al.. (2022). A differential process mining analysis of COVID-19 management for cancer patients. Frontiers in Oncology. 12. 1043675–1043675. 3 indexed citations
6.
Vionnet, Julien, Michel Obéid, Hasna Bouchaab, et al.. (2022). Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer. 10(10). e005635–e005635. 20 indexed citations
7.
Gérard, Camille L., Alexandre Wicky, Grégoire Berthod, et al.. (2022). Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma. Cancers. 15(1). 31–31. 4 indexed citations
8.
Galea, Claire, Serigne Lo, Florentia Dimitriou, et al.. (2022). Efficacy and safety of "second adjuvant" therapy with BRAF/MEK inhibitors after resection of recurrent melanoma following adjuvant PD-1–based immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 9575–9575. 6 indexed citations
9.
Bhave, Prachi, Tasnia Ahmed, Alexander N. Shoushtari, et al.. (2021). 1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM). Annals of Oncology. 32. S876–S877. 3 indexed citations
10.
Gérard, Camille L., Julie Delyon, Alexandre Wicky, et al.. (2021). Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treatment Reviews. 101. 102227–102227. 72 indexed citations
11.
Gérard, Camille L., Alexandre Wicky, Grégoire Berthod, et al.. (2021). Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients.. Journal of Clinical Oncology. 39(15_suppl). e21529–e21529. 1 indexed citations
12.
Özdemir, Berna C., Camille L. Gérard, Alexandre Wicky, et al.. (2020). 7P Comparison of the clinical utility of two different size next generation sequencing (NGS) gene panels for solid tumours. Annals of Oncology. 31. S1219–S1219. 1 indexed citations
13.
Gérard, Camille L., Alexandre Wicky, Edoardo Missiaglia, et al.. (2020). Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology. International Journal of Molecular Sciences. 21(21). 8021–8021. 1 indexed citations
14.
Ghisoni, Eleonora, Alexandre Wicky, Sofiya Latifyan, et al.. (2020). Long-lasting, irreversible and late-onset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis.. Journal of Clinical Oncology. 38(15_suppl). e15095–e15095. 3 indexed citations
15.
Wicky, Alexandre, et al.. (2019). Death in the Emergency Department: A Retrospective Analysis of Mortality in a Swiss University Hospital. Emergency Medicine International. 2019. 1–9. 15 indexed citations
16.
Martins, Filipe, Luis Schiappacasse, Marc Levivier, et al.. (2019). The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study. Journal of Neuro-Oncology. 146(1). 181–193. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diego Enrico Breakdown of academic impact, for papers by Aleigha Lawless Breakdown of academic impact, for papers by Yu Yu Breakdown of academic impact, for papers by Laurien J. Zeverijn Breakdown of academic impact, for papers by David García-Illescas Breakdown of academic impact, for papers by Ryan Massa Breakdown of academic impact, for papers by Meera Patel Breakdown of academic impact, for papers by Kimberly Tang Breakdown of academic impact, for papers by Yuequan Shi Breakdown of academic impact, for papers by Ramdane Belhocine
Rankless by CCL
2026